'Liquid biopsy' presentation slideshows

Cancer Diagnostics Market

Cancer continues to be one of the most lethal diseases among humans, despite years of considerable progress made in its diagnosis and treatment. According to the World Health Organization, cancer is the second most frequent cause of death in the world, with 8.8 million people dying from this disease in 2015 alone.

157 views • 14 slides

Liquid Biopsy Market to be US$ 3.4 Billion by 2024

Access Full Research: https://www.renub.com/liquid-biopsy-market-p.php As per Renub Research analysis Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has paved the road of cancer diagnosis and treatment by offering a complete treatment response in real time without the need of serial traditional (solid-tissue) biopsies. Today, the population across the globe is growing and aging and so is the global burden of cancer; it is estimated that by the year 2030, the global cancer burden will reach nearly 21.7 Million new cancer cases and be around 13 Million cancer deaths. It is also expected that the low and middle income countries accounts for 60% of the cancer deaths due to the lack of medical resources and proper healthcare systems.

252 views • 14 slides

Liquid Biopsy Market is projected to surpass US$ 3.4 Billion by 2024

186 views • 14 slides

Healthcare is Drowning in data

Explains about how data and omics revolutioninzing Healthcare and how healthcare moving towards preventive from curative with the help of data. For more information visit: http://www.transformhealth-it.org/

243 views • 13 slides

Liquid Biopsy Potential Testing Market Analysis to 2020-United States

262 views • 13 slides

Liquid Biopsy Market Projected to Reach 1.66 Billion USD by 2021

The liquid biopsy market is expected to reach USD 1.66 Billion by 2021 from USD 0.58 Billion in 2016, growing at a CAGR of 23.4% during the forecast period of 2016 to 2021.

259 views • 12 slides

Liquid Biopsy Market Size

Global liquid biopsy market was achieved through exhaustive analysis of some of the key macro-economic factors: annual healthcare spending, annual per capita healthcare expenditure, and financial burden of cancer, among others. The statistical information pertaining to the key contributing nations of global liquid biopsy market was composed together and examined to evaluate their impact on the growth of liquid biopsy market in each nation.

120 views • 10 slides

Liquid Biopsy Market size and Key Trends in terms of volume and value 2016-2026

187 views • 7 slides

Global Infectious Disease Diagnostics Market

Global Infectious Disease Diagnostics Market is expected to increase from USD 14.45 Billion in 2016 to USD 29.43 Billion in 2024 at a CAGR 9.3%.

73 views • 7 slides

Global liquid biopsy market

Global liquid biopsy market is expected to reach USD 3005.69 Million by 2024 with CAGR of 22.78% from USD 582.17 Million in 2016.

73 views • 7 slides

Public Disclosure from Dr. Howard Urnovitz

Public Disclosure from Dr. Howard Urnovitz. One life, one test. FBB, Inc. The Opportunity : Medicine is now curing major diseases The Problem : Too few patients benefit because monitoring the therapy takes months to evaluate and at too high a cost The Solution :

385 views • 6 slides

Global Liquid Biopsy Industry Market Growth Analysis and 2020 Forecast

2015 Global Liquid Biopsy industry in-depth market research reports added in Sep. 2015 by DeepResearchReports.com to its Diagnostics store.

353 views • 5 slides

Global Liquid Biopsy Market Research Report- Forecast to 2022

Global Liquid Biopsy Market Information, by Biomarker Types (Circulating Tumor Cells (Ctcs), Circulating Tumor Dna (Ctdna), Extracellular Vesicles (Evs) and Other Biomarker (Circulating Rna And Proteins), by Application (Cancer Therapeutic Application, Reproductive Health, Other Therapeutic Application), by Sample (Blood Sample, Urine Sample, Other) And End User (Hospitals and Laboratories, Academic And Research Centers, Other End Users) - Forecast to 2022

54 views • 4 slides

Global Liquid Biopsy Market Research Report- Forecast to 2022

Global Liquid Biopsy Market Information, by Biomarker Types (Circulating Tumor Cells (Ctcs), Circulating Tumor Dna (Ctdna), Extracellular Vesicles (Evs) and Other Biomarker (Circulating Rna And Proteins), by Application (Cancer Therapeutic Application, Reproductive Health, Other Therapeutic Application), by Sample (Blood Sample, Urine Sample, Other) And End User (Hospitals and Laboratories, Academic And Research Centers, Other End Users) - Forecast to 2022

73 views • 4 slides

Liquid Biopsy Market by key players - Biocept Inc., Myriad Genetics, QIAGEN, Roche, Bio-Rad Laboratories Inc.

The Global Liquid Biopsy Market is expected to exceed more than US$ 2 billion by 2022 and will grow at a CAGR of more than 23% in the given forecast period.

86 views • 4 slides

Liquid Biopsy Market 2017 Product Type, Market price, Production Area , Analysis by Regions, Development Trend, Manufact

A liquid biopsy is a simple and non-invasive technique that enables to discover a range of information about a tumor through a simple blood sample.

52 views • 4 slides

Global Liquid Biopsy Market - Size, Trends and Forecast to 2025

A liquid biopsy is a simple and non-invasive technique that enables to discover a range of information about a tumor through a simple blood sample.

45 views • 4 slides

Liquid Biopsy Products Market to Show Significant Growth Over the Forecast Period

36 views • 3 slides

Liquid Biopsy Market

Global Liquid Biopsy Market Information, by Biomarker Types (Circulating Tumor Cells (Ctcs), Circulating Tumor Dna (Ctdna), Extracellular Vesicles (Evs) and Other Biomarker (Circulating Rna and Proteins), by Application (Cancer Therapeutic Application, Reproductive Health, Other Therapeutic Application), by Sample (Blood Sample, Urine Sample, other) and End User (Hospitals and Laboratories, Academic And Research Centers, other End Users) - Forecast to 2022

25 views • 2 slides

Figure 1 Release and extraction of cfDNA from the blood

Figure 1 Release and extraction of cfDNA from the blood. Crowley, E. et al. ( 2013) Liquid biopsy: monitoring cancer-genetics in the blood Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.110.

364 views • 1 slides